Opinion | What Does the Recent Pig-to-Human Kidney Transplant Mean for Tissue Therapeutics?
In a pioneering procedure, a team of surgeons at New York University Langone Health Grossman School of Medicine in New...
Alitame Excipient | Uses, Suppliers, and Specifications
Description
Chemical Structure & Identifiers
Regulatory Status
Physicochemical Properties
Pharmacopeoeal Specifications
Applications in Pharmaceutical Formulations or Technology
Safety and Precautions
Stability and Storage Conditions
Sustainability and Environmental Impact
Manufacturers & Suppliers
Alitame is a synthetic intense sweetener that was developed by Pfizer. It corresponds to l-α-aspartyl-N-(2,2,4,4-tetramethyl-3-thioethanyl)-d-alaninamide] making it an amino acid-based sweetener. It is approximately 2000 times sweeter than sucrose, 12 times sweeter than aspartame, and six times sweeter than saccharin. It is supplied as a white, crystalline powder with a characteristic sweet taste.
Pharmacopoeial Compliance: USP-NF
Synonyms and Trade Names: Alitame; L-Aspartyl-D-Alanine-N-(2,2,4,4-Tetramethylthietan-3-Yl)Amide; 3-(L-Aspartyl-D-Alaninamido)-2,2,4,4-Tetramethylthietane; Aclame
Uses and Applications: Intense Sweetener
Additional Resources (Downloads)
References and Literature Used
FAQS
[bsa_pro_ad_space id=2]
[bsa_pro_ad_space id=4]
Related products
DISCLAIMER
PharmaCentral.com may on occasion publish user-generated content. Any information provided on our platform is for general informational and educational purposes only. All information is provided in good faith to enable collaboration and sharing of know-how among our community of users. Authors who submit content retain copyright to it.
PharmaCentral.com does not make any representation or warranty of any kind regarding its accuracy, adequacy, or legality. Any references to particular product names, brands, descriptions, formats, styles, corporate entities, tests, applications, technologies, uses, standardisations, medical conditions, and treatments are for illustration purposes and should not be considered complete or binding. All respective intellectual property, such as trademarks and logos, are properties of their owners
Fair Use Copyright Disclaimer
Under Section 107 of the Copyright Act 1976, allowance is made for ‘Fair Use’ for purposes such as criticism, comment, news, reporting, scholarship, education, and research.
Fair use is a use permitted by copyright statute that might otherwise be infringing.
Some information contained on PharmaCentral.com may contain copyrighted material, the use of which may not have been specifically authorised by the respective copyright owners. Some material is made available to help explain and relay complex phenomena, formulae, physical and chemical constants, and other concepts that are scientifically incontestable but relevant to the use of products, and/or to illustrate, transmit, and teach pharmaceutical science principles. Some material is published to support research and user education, and for the public good.